Issue |
Title |
File |
Vol 10, No 1 (2013) |
Real and potential benefits of third-generation calcium antagonists |
|
Kirichenko A.A.
|
Vol 14, No 2 (2017) |
Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) |
(Rus)
|
Marwick T.H., Gillebert T.C., Aurigemma G., Chirinos J., Derumeaux G., Galderisi M., Gottdiener J., Haluska B., Ofili E., Segers P., Senior R., Tapp R.J., Zamorano J.L., Khadzegova A.B., Matskeplishvili S.T., Krikunov P.V.
|
Vol 11, No 2 (2014) |
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders |
(Rus)
|
Zhernakova Y.V., Chazova I.E.
|
Vol 8, No 4 (2011) |
Regress subklinicheskogo porazheniya organov-misheney u bol'nykh gipertonicheskoy bolezn'yu na fone razlichnykh podkhodov k naznacheniyu kombinirovannoy antigipertenzivnoy terapii |
|
Bushmakina A.V., Koziolova N.A., Kovalevskaya N.A.
|
Vol 16, No 3 (2019) |
Regulatory adaptive status in determining the effectiveness of lisinopril and fosinopril in patients with chronic heart failure with preserved left ventricular ejection fraction |
(Rus)
|
Nedvetskaia S.N., Shubitidze I.Z., Tregubov V.G., Pokrovskiy V.M.
|
Vol 13, No 4 (2016) |
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal atrial fibrillation |
(Rus)
|
Eremina M.A., Tregubov V.G., Pokrovsky V.M.
|
Vol 14, No 4 (2017) |
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia |
(Rus)
|
Nazhalkina N.M., Tregubov V.G., Pokrovsky V.M.
|
Vol 13, No 1 (2016) |
Regulatory adaptive status in determining the effectivenessof bisoprololum and sotalolum in patients with hypertensive disease and ventricular arrhythmias |
(Rus)
|
Shubitidze I.Z., Tregubov V.G., Pokrovsky V.M.
|
Vol 8, No 2 (2011) |
Regulyatorno-adaptivnyy statuspatsientov s gipertonicheskoybolezn'yu pri medikamentoznomdostizhenii tselevykh urovneyarterial'nogo davleniya |
|
Pokrovskiy V.M., Kompaniets O.G.
|
Vol 10, No 3 (2013) |
Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii |
|
Mancia G., Fagard R.
|
Vol 10, No 4 (2013) |
Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii |
|
Mancia G., Fagard R.
|
Vol 5, No 3 (2008) |
Rekomendatsii po diagnostike i lecheniyu arterial'noy gipertonii 2008: chto novogo? |
|
Chazova I.E., Ratova L.G.
|
Vol 14, No 4 (2017) |
Relationship between selected populations of leukocytes and cardiovascular system activity in women with essential hypertension |
(Rus)
|
Kuznik B.I., Davydov S.O., Guseva E.S., Stepanov A.V., Smolyakov Y.N., Tsybikov N.N., Fine I.V., Magen E.
|
Vol 18, No 3 (2021) |
Renal artery denervation in patients with resistant arterial hypertension: clinical and organ-protective effect |
(Rus)
|
Gapon L.I., Mikova E.V., Krinochkin D.V., Savelyeva N.Y., Zherzhova A.Y., Aleksandrovich E.L.
|
Vol 6, No 1 (2009) |
Renovaskulyarnaya arterial'naya gipertenziya: diagnostika i lechenie |
|
Danilov N.M., Chazova I.E., Savchenko A.P.
|
Vol 15, No 3 (2018) |
Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment |
(Rus)
|
Aksenova A.V., Esaulova T.E., Sivakova O.A., Chazova I.E.
|
Vol 3, No 1 (2006) |
Restenoz posle koronarnogo stentirovaniya u bol'nykh s metabolicheskim sindromom |
|
Danilov N.M., Gorgadze T.T., Savchenko A.P., Chazova I.E.
|
Vol 12, No 2 (2015) |
Restriction of caloric intake is a key to prevention of vascular ageing |
(Rus)
|
Orlova Y.A.
|
Vol 17, No 1 (2020) |
Results of pulmonary thromboendarterectomy depending on different levels of pulmonary vascular resistance and angiographic index of the pulmonary artery lesion |
(Rus)
|
Gazizov V.V., Mershin K.V., Tabak’yan E.A., Partigulov S.A., Valieva Z.S., Martynyuk T.V., Akchurin R.S.
|
Vol 7, No 1 (2010) |
Rezul'taty farmakoepidemiologicheskogo issledovaniya arterial'noy gipertonii PIFAGOR III |
|
Leonova M.V., Belousov D.Y., Shteynberg L.L., Galitskiy A.A., Belousov Y.B.
|
Vol 7, No 2 (2010) |
Rezul'taty farmakoepidemiologicheskogo issledovaniya arterial'noy gipertonii PIFAGOR III (opros patsientov s AG) |
|
Leonova M.V., Belousov Y.B., Shteynberg L.L., Galitskiy A.A., Belousov D.Y.
|
Vol 5, No 2 (2008) |
Rezul'taty programmy «BazOvoe LEchenie i antigipertenzivnyy effekt: preparat Ravel SR u patsientov s arterial'nOy gipertoniey» (BOLERO) |
|
Glezer M.G., Saygitov R.T.
|
Vol 10, No 4 (2013) |
Riociguatas the first innovative guanylatecyclase stimulators class drugs for pulmonary arterial hypertension patients treatment |
|
Chazova I.E., Martynyuk T.V.
|
Vol 16, No 4 (2019) |
Risk factors for falls in patients with arterial hypertension |
(Rus)
|
Khovasova N.O., Naumov A.V., Tkacheva O.N., Moroz V.I.
|
Vol 11, No 1 (2014) |
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components |
(Rus)
|
Zhernakova Y.V., Sharipova G.K., Chazova I.E.
|
Vol 7, No 2 (2010) |
Rol' fraktalkina v patogeneze idiopaticheskoy legochnoy gipertenzii |
|
Nakonechnikov S.N., Zykov K.A., Martynyuk T.V., Masenko V.P., Chazova I.E.
|
Vol 9, No 1 (2012) |
Rol' giperaktivnosti simpaticheskoy nervnoy sistemy v razvitii serdechno-sosudistykh zabolevaniy i vozmozhnosti farmakologicheskoy korrektsii |
|
Dorofeeva G.B., Dorofeev V.I., Trofimova Y.V.
|
Vol 5, No 4 (2008) |
Rol' moksonidina v kombinirovannoy antigipertenzivnoy terapii patsientov s metabolicheskim sindromom |
|
Podzolkov V.I., Bragina A.E., Gladysheva E.A.
|
Vol 4, No 2 (2007) |
Rol' radionuklidnykh metodov issledovaniya pri arterial'noy gipertonii |
|
Samoylenko L.E., Sergienko V.B.
|
Vol 9, No 2 (2012) |
Rol' sildenafila v lechenii bol'nykh legochnoy arterial'noy gipertenziey |
|
Martynyuk T.V., Chazova I.E.
|
Vol 4, No 1 (2007) |
Rol' sutochnogo monitorirovaniya arterial'nogo davleniya v otsenke effektivnosti antigipertenzivnoy terapii (Rezul'taty sutochnogo monitorirovaniya arterial'nogo davleniya v programme KLIP-AKKORD) |
|
Chazova I.E., Ratova L.G.
|
Vol 10, No 3 (2013) |
Rol' trimetazidina v regulyatsii energeticheskogo metabolizma miokarda pri serdechno-sosudistykh zabolevaniyakh |
|
Dorofeeva G.B., Dorofeev I.V., Trofimova Y.V., Manerova O.V.
|
Vol 16, No 4 (2019) |
Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old? |
(Rus)
|
Adasheva T.V., Samorukova E.I., Zadionchenko V.S., Laricheva K.A.
|
Vol 11, No 4 (2014) |
Role of the Pulse Oximetry in the cardiologist's practice |
(Rus)
|
Aksenova A.V., Yelfimova Y.M., Galitsin P.V., Goriyeva S.B., Bugayev T.D., Mikhailova O.O., Litvin A.Y., Rogoza A.N., Chazova I.Y.
|
Vol 3, No 2 (2006) |
Rossiyskaya programma LIDER: otsenka izmeneniya kachestva zhizni boL'nykh Ishemicheskoy bolezn'yu serDtsa na fonE teRapii liprimarom |
|
Karpov Y.A., Deev A.D.
|
Vol 8, No 2 (2011) |
Rossiyskie nablyudatel'nyeissledovaniya valsartanai kombinirovannoyantigipertenzivnoy terapiina ego osnove |
|
Karpov Y.A., Podzolkov V.I., Fomin V.V., Vigdorchik A.V.
|
Vol 1, No 1 (2004) |
Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya) |
|
Chazova I.E.
|
Vol 17, No 3 (2020) |
Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19 |
(Rus)
|
Chazova I.E., Blinova N.V., Nevzorova V.A., Zhernakova J.V., Savenkov M.P., Oshchepkova E.V., Ostroumova O.D., Kisliak O.A., Boytsov S.A.
|
Vol 17, No 4 (2020) |
Russian medical society on arterial hypertension (RMSAH) Consensus of Experts on the use of radiofrequency denervation of the renal arteries in patients with arterial hypertension |
(Rus)
|
Danilov N.M., Agaeva R.A., Matchin Y.G., Grigin V.A., Shchelkova G.V., Ripp T.M., Pekarskii S.E., Baev A.E., Chazova I.Е.
|
Vol 12, No 1 (2015) |
Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases |
(Rus)
|
Dolgusheva Y.A., Agapova O.Y., Zykov K.A., Chazova I.E.
|
Vol 2, No 1 (2005) |
Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora? |
|
Shestakova M.V.
|
Vol 1, No 2 (2004) |
Samokontrol' arterial'nogo davleniya patsientami povyshaet priverzhennost' k lecheniyu arterial'noy gipertonii (nablyudenie 1 god) |
|
Oshchepkova E.V., Tsagareishvili E.V., Rogoza A.N.
|
Vol 5, No 3 (2008) |
Samostoyatel'noe izmerenie arterial'nogo davleniya v domashnikh usloviyakh |
|
Ratova L.G., Chazova I.E., Boytsov S.A.
|
Vol 6, No 2 (2009) |
Sartans in cardiological practice: new possibilities in therapy of cardiovascular diseases |
|
Smolenskaya O.G.
|
Vol 10, No 2 (2013) |
Sartans in the treatment of high-risk hypertension: the abilities of candesartan |
|
Morozova T.E.
|
Vol 12, No 2 (2015) |
Ser49Gly polymorphic markers associations of ADRB1 gene and 4a/4b eNOS gene with hypertension and ischemic heart disease among the population of mountain shoria natives |
(Rus)
|
Mulerova T.A., Rubtsova E.V., Kuz'mina A.A., Tatarnikova N.P., Maksimov V.N., Voevoda M.I., Ogarkov M.I.
|
Vol 4, No 1 (2007) |
Simptomaticheskaya arterial'naya gipertoniya pri pervichnom i vtorichnom giperal'dosteronizme |
|
Chikhladze N.M., Chazova I.E.
|
Vol 10, No 3 (2013) |
Sindrom obstruktivnogo apnoe sna i disfunktsiya endoteliya |
|
Galitsin P.V., Aksenova A.V., Elfimova E.M., Ishankhodzhaeva G.R., Balakhonova T.V., Litvin A.Y., Chazova I.E.
|
Vol 3, No 1 (2006) |
Sindrom obstruktivnogo apnoe vo vremya sna i arterial'naya gipertenziya |
|
Chazova I.E., Litvin A.Y.
|
Vol 8, No 1 (2011) |
Skoraya meditsinskaya pomoshch' pri povyshenii arterial'nogo davleniya. |
|
Ruksin V.V., Grishin O.V., Yashchenkova S.V., Onuchin M.V.
|
Vol 8, No 4 (2011) |
Sluchay povrezhdeniya serdtsa ostroy igloy, simuliruyushchiy kliniku ostrogo koronarnogo sindroma |
|
Zakharova N.V., Bratslavskiy V.B., Yaromich A.F., Svirido D.A.
|
Vol 8, No 1 (2011) |
Sol'-chuvstvitel'nost' i arterial'naya gipertenziya: fundamental'naya patogeneticheskaya vzaimosvyaz' - mishen' dlya farmakologicheskikhvozdeystviy. |
|
Fomin V.V., Pulin A.A.
|
Vol 9, No 2 (2012) |
Sostoyanie funktsii endoteliya u bol'nykh podagroy s arterial'noy gipertenziey |
|
Kushnarenko N.N., Govorin A.V., Kushnarenko K.E.
|
Vol 7, No 4 (2010) |
Sostoyanie vegetativnogo statusa i ego vzaimosvyaz' s gumoral'nymi faktorami u zhenshchin v perimenopauze |
|
Podzolkov V.I., Bragina A.E., Panferova E.K.
|
Vol 8, No 3 (2011) |
Sovremennye aspektyfarmakoterapii arterial'noygipertenzii. Vozmozhnosti urapidila |
|
Morozova T.E.
|
Vol 5, No 4 (2008) |
Sovremennye podkhody k diagnostike raznykh form arterial'noygipertenzii v svete natsional'nykh rekomendatsiy |
|
Chazova I.E., Ratova L.G., Mychka V.B., Boytsov S.A.
|
Vol 1, No 2 (2004) |
Sovremennye predstavleniya o roli prostaglandinov v lechenii bol'nykh legochnoy gipertenziey |
|
Matvienko O.O., Martynyuk T.V., Chazova I.E.
|
Vol 18, No 1 (2021) |
Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension |
(Rus)
|
Sobolev A.V., Ryabykina G.V., Kozhemyakina E.S.
|
Vol 17, No 3 (2020) |
Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension |
(Rus)
|
Avalyan A.A., Saidova M.A., Oshchepkova E.V., Chazova I.E.
|
Vol 5, No 4 (2008) |
Sravnenie effektivnosti i bezOpasnosti rannego primeneniya zoFenOprila i Kaptoprila v Lechenii patsientov s ostrym infarktom miokarda (SOFOKL-1).Pervye rezul'taty issledovaniya |
|
Arutyunov G.P., Rozanov A.V., Dayter I.I., Arutyunov A.G., Bykov V.A., Volkova A.L., Plieva I.M., Stogov A.V., Marfunina A.A.
|
Vol 9, No 1 (2012) |
Sravnitel'naya effektivnost' antigipertenzivnykh preparatov v korrektsii giperinsulinemii u patsientov s arterial'noy gipertenziey bez narusheniy uglevodnogo obmena |
|
Kanyukova A.A., Smolenskaya O.G.
|
Vol 5, No 1 (2008) |
Sravnitel'naya effektivnost' eprosartana i enalaprila u bol'nykh arterial'noy gipertoniey |
|
Osipova I.V., Antropova O.N., Kuznetsova E.I., Lobanova N.A.
|
Vol 7, No 3 (2010) |
Sravnitel'naya effektivnost' lecheniya dvumya raznymi preparatami lizinoprila v vide monoterapii i v kombinatsii s gidrokhlorotiazidom u patsientov s arterial'noy gipertoniey |
|
Abdullaev A.A., Shakhbieva Z.Y., Islamova U.A., Gafurova R.M.
|
Vol 9, No 1 (2012) |
Sravnitel'naya effektivnost' perindoprila A i telmisartana u patsientov s arterial'noy gipertenziey i ozhireniem |
|
Nedogoda S.V., Ledyaeva A.A., Chumachok E.V., Tsoma V.V., Mazina G.G., Salasyuk A.S., Barykina I.N.
|
Vol 1, No 2 (2004) |
Sravnitel'naya otsenka antigipertenzivnogo i kardioprotektivnogo effektov lozartana i ego fiksirovannoy kombinatsii s gidrokhlortiazidom |
|
Ratova L.G., Ataullakhanova D.M., Tolpygina S.N., Chazova I.E.
|
Vol 1, No 1 (2004) |
Sravnitel'naya otsenka antigipertenzivnoy effektivnosti lozartana i ego fiksirovannoy kombinatsii s gidrokhlortiazidom pri 24-nedel'noy terapii u bol'nykh gipertonicheskoy bolezn'yu |
|
Ratova L.G., Tolpygina S.N., Chazova I.E.
|
Vol 8, No 1 (2011) |
Sravnitel'naya otsenka klinicheskoy effektivnosti i bezopasnosti β1-adrenoblokatora bisoprolola i antagonista kal'tsiya verapamilau bol'nykh stabil'noy stenokardiey v sochetanii s khronicheskoy obstruktivnoy bolezn'yu legkikh (rezul'taty dvukhletnego nablyudeniya). |
|
Grigor'eva N.Y., Kuznetsov A.N., Nekrasov A.A., Koroleva T.V.
|
Vol 8, No 3 (2011) |
Sravnitel'naya otsenka razlichnogovybora initsiiruyushcheyantigipertenzivnoy terapiiv korrektsii porazheniyaorganov-misheney u bol'nykhgipertonicheskoy bolezn'yu |
|
Koziolova N.A., Kovalevskaya N.A., Bushmakina A.V., Petrova N.Y.
|
Vol 7, No 4 (2010) |
Sravnitel'nyy analiz antigipertenzivnogo i metabolicheskikh effektov ingibitorov angiotenzinprevrashchayushchego fermentapri monoterapii i v kombinatsii s gidrokhlorotiazidom. |
|
Mamedov M.N., Stroeva M.V.
|
Vol 4, No 2 (2007) |
S-reaktivnyy belok – vektor perenosa zhirnykh kislot, test endogennogo vospaleniya pri arterial'noy gipertonii |
|
Titov V.N.
|
Vol 15, No 2 (2018) |
State of the art for diagnosis and treatment of orthostatic hypotension |
(Rus)
|
Aksenova A.V., Gorieva S.B., Rogoza A.N., Sivakova O.A., Esaulova T.E., Chazova I.E.
|
Vol 5, No 1 (2008) |
Statiny pri metabolicheskom sindrome i AG Po rezul'tatam programmy «ROZA» - ROZuvastatin u patsientov s Arterial'noy gipertoniey |
|
Kukharchuk V.V., Chazova I.E., Ratova L.G.
|
Vol 9, No 3 (2012) |
Strategiya antigipertenzivnoy terapii u pozhilykh bol'nykh arterial'noy gipertenziey s vysokim riskom serdechno-sosudistykh oslozhneniy: rezul'taty Rossiyskogo issledovaniya KhARIZMA-3 |
|
Chazova I.E., Martynyuk T.V., Nebieridze D.V., Nedogoda S.V., Ratova L.G.
|
Vol 13, No 2 (2016) |
Strategy of medical treatment of pulmonary arterial hypertension in the current international recommendations |
(Rus)
|
Martyniuk T.V., Chazova I.E.
|
Vol 9, No 4 (2012) |
Stress-induced arterial hypertension – clinical features and treatment options |
|
Ratova L.G., Chazova I.E.
|
Vol 15, No 2 (2018) |
Stroke prevention in patients with atrial fibrillation and comorbidities |
(Rus)
|
Ostroumova O.D., Voevodina N.Y., Guseva T.F., Pavleeva E.E., Piksina G.F., Goloborodova I.V.
|
Vol 11, No 2 (2014) |
Study of the relationship social and psychological characteristics of hypertensive patients, the frequency of medical emergencies and adherence of patients to treatment |
(Rus)
|
Chumakova E.A., Gaponova N.I.
|
Vol 10, No 2 (2013) |
Subclinical vessel lesion in normotensive patients with abdominal obesity: focus on arterial stiffness |
|
Druzhilov M.A., Otmakhov V.V., Beteleva Y.E., Korneva V.A., Kuznetsova T.Y.
|
Vol 10, No 4 (2013) |
Summer School on hypertension 2013 in Portugal |
|
Arkhipova O.A., Starostin I.V.
|
Vol 14, No 3 (2017) |
Survival of patients with pulmonary arterial hypertension during therapy PAH-specific drugs |
(Rus)
|
Platonov D.Y., Tsareva N.A., Avdeev S.N.
|
Vol 8, No 2 (2011) |
Svyaz' chisla komponentovmetabolicheskogo sindromas rasprostranennost'yui vyrazhennost'yu porazheniyaorganov-misheney |
|
Zhernakova Y.V., Chazova I.E., Mychka V.B., Olimpieva S.P., Kilikovskiy V.V.
|
Vol 16, No 4 (2019) |
Target blood pressure levels in patients with arterial hypertension and frailty |
(Rus)
|
Ostroumova O.D., Cherniaeva M.S., Morozov A.P.
|
Vol 16, No 3 (2019) |
Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty |
(Rus)
|
Ostroumova O.D., Cherniaeva M.S.
|
Vol 3, No 2 (2006) |
Terapiya irbesartanom bol'nykh sakharnym diabetom tipa 2: metabolicheskie effekty i vliyanie na perfuziyu golovnogo mozga |
|
Mamyrbaeva K.M., Mychka V.B., Masenko V.P., Sergienko V.B., Chazova I.E.
|
Vol 9, No 4 (2012) |
The 2012 hypertension summer school in Dublin (Ireland) |
|
Blinova N.V., Elfimova E.M.
|
Vol 9, No 4 (2012) |
The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia |
|
Nedogoda S.V., Ledyaeva A.A., Chumachok E.V., Tsoma V.V., Salasyuk A.S.
|
Vol 13, No 4 (2016) |
The application of ivabradine in the management of ischaemic heart disease |
(Rus)
|
Gurevich M.A., Kuzmenko N.A.
|
Vol 11, No 4 (2014) |
The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches |
(Rus)
|
Gilyarevsky S.R., Kuzmina I.M., Golshmid M.V.
|
Vol 12, No 1 (2015) |
The association of arterial hypertension and ischemic heart disease is the main problem in modern cardiology practice |
(Rus)
|
Ostroumova O.D., Dudaev V.A., Fomina V.M.
|
Vol 9, No 4 (2012) |
The availability of a home tonometer as a factor that increases therapy compliance in outpatients with arterial hypertension |
|
Smirnova M.D., Tsygareishvili E.V., Ageyev F.T., Svirida O.N., Kuzmina A.E., Fofanova T.V.
|
Vol 11, No 2 (2014) |
The benefits of candesartan usage in the treatment of arterial hypertension |
(Rus)
|
Ostroumova O.D., Bondarets O.V., Guseva T.F.
|
Vol 9, No 4 (2012) |
The capacities of automated oscillometric blood pressure measuring devices in patients with atrial fibrillation |
|
Rogoza A.N., Goriyeva S.B.
|
Vol 13, No 4 (2016) |
The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide |
(Rus)
|
Ostroumova O.D., Garelik I.A., Karavashkina E.A.
|
Vol 11, No 3 (2014) |
The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’) |
(Rus)
|
Ostroumova O.D., Guseva T.F., Bondarets O.V.
|
Vol 6, No 3 (2009) |
The combination therapy: when efficiency and safety go an arm about arm |
|
Chazova I.E., Ratova L.G.
|
Vol 10, No 4 (2013) |
The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency |
|
Shiganov S.V., Baev V.V., Shulbayev A.P.
|
Vol 6, No 4 (2009) |
The condition of parameters of memory, attention and thinking at men of young age officers under the contractwith arterial hypertension. |
|
Davidovich I.M., Afonaskov O.V., Staroverova Y.K.
|
Vol 13, No 4 (2016) |
The control of blood pressure level as the prevention of cognitive impairment |
(Rus)
|
Melnik M.V., Afonicheva I.I., Kazyulin A.A.
|
Vol 12, No 2 (2015) |
The correlation of the efficacy and safety of statins with the aim of primary and secondary prevention: myths and reality |
(Rus)
|
Gilyarevsky S.R., Golshmid M.V., Kuzmina I.M.
|
Vol 11, No 4 (2014) |
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension |
(Rus)
|
Valieva Z.S., Valeeva E.G., Glukhova S.I., Martynyuk T.V., Chazova I.E.
|
501 - 600 of 734 Items |
<< < 1 2 3 4 5 6 7 8 > >> |